Citigroup’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-167,471
| Closed | -$4.91M | – | 7757 |
|
|
2017
Q3 | $4.91M | Buy |
167,471
+129,588
| +342% | +$3.63M | ﹤0.01% | 1787 |
|
|
2017
Q2 | $995K | Buy |
37,883
+2,480
| +7% | +$61K | ﹤0.01% | 3319 |
|
|
2017
Q1 | $829K | Sell |
35,403
-26,977
| -43% | -$666K | ﹤0.01% | 3410 |
|
|
2016
Q4 | $1.57M | Buy |
62,380
+34,678
| +125% | +$876K | ﹤0.01% | 3211 |
|
|
2016
Q3 | $778K | Buy |
27,702
+3,349
| +14% | +$85.8K | ﹤0.01% | 3480 |
|
|
2016
Q2 | $601K | Buy |
24,353
+2,202
| +10% | +$54.6K | ﹤0.01% | 3462 |
|
|
2016
Q1 | $489K | Buy |
22,151
+21,663
| +4,439% | +$577K | ﹤0.01% | 4136 |
|
|
2015
Q4 | $17K | Buy |
488
+483
| +9,660% | +$15.1K | ﹤0.01% | 6586 |
|
|
2015
Q3 | $0 | Sell |
5
-427
| -99% | -$14.3K | ﹤0.01% | 8029 |
|
|
2015
Q2 | $14K | Sell |
432
-345
| -44% | -$10.6K | ﹤0.01% | 6310 |
|
|
2015
Q1 | $21K | Sell |
777
-21,161
| -96% | -$526K | ﹤0.01% | 6088 |
|
|
2014
Q4 | $454K | Buy |
21,938
+17,478
| +392% | +$415K | ﹤0.01% | 3971 |
|
|
2014
Q3 | $109K | Buy |
4,460
+3,324
| +293% | +$88.1K | ﹤0.01% | 4694 |
|
|
2014
Q2 | $32K | Sell |
1,136
-15,358
| -93% | -$427K | ﹤0.01% | 5492 |
|
|
2014
Q1 | $462K | Sell |
16,494
-16,593
| -50% | -$407K | ﹤0.01% | 3545 |
|
|
2013
Q4 | $711K | Buy |
33,087
+18,352
| +125% | +$334K | ﹤0.01% | 3497 |
|
|
2013
Q3 | $195K | Sell |
14,735
-8,585
| -37% | -$116K | ﹤0.01% | 4174 |
|
|
2013
Q2 | $322K | Buy |
+23,320
| New | +$330K | ﹤0.01% | 3858 |
|
Citigroup's PMC Position: Q4 2017 in Review
Citigroup sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 167,471 shares — an estimated $4.91M sold.
Citigroup first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $4.91M in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Citigroup reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Citigroup sold 167,471 PharMerica Corporation shares in Q4 2017, an estimated $4.91M.
- Citigroup first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Citigroup's PharMerica Corporation position peaked at $4.91M in Q3 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Citigroup's 13F filing for Q4 2017, filed 12 Feb 2018.